Vivani Medical To Perform Clinical Study For Miniature

Medical, Inc., an innovative biopharmaceutical business developing unique, long-term medication implants, said that the first clinical study in the NPM-115 program is expected to begin in Australia in the fourth quarter of 2024, subject to...

China Nods CSPC Pharma's RSV Vaccine for Clinical Trials

The National Medical Products Administration of China has approved CSPC Pharmaceutical Group's respiratory syncytial virus (RSV) vaccine candidate for human clinical trials, the company announced. RSV, which causes symptoms similar to a cold but...

Eisai Bags Hong Kong Regulatory Nod For Leqembi To Treat Alzheimers

The Swedish biopharma company BioArctic AB announced that its partner Eisai has been granted approval by the Department of Health in Hong Kong for the treatment of Alzheimer's disease with Leqembi. Patients who are in the mild cognitive impairment...

NovaBay Pharma Reports USD 2.4 Million in Q2 Revenue

NovaBay Pharmaceuticals, a leading biopharmaceutical firm, delcares preliminary net revenue for the second quarter of 2024 of USD 2.4 million and for the first half of 2024 of $5.0 million, primarily derived from the firm's eyecare products. Net...

Indegene Partners with Microsoft to Boost GenAI in Life Science Firms

Indegene, a life sciences commercialization firm, has announced a strategic partnership with Microsoft to help global life sciences organizations accelerate the adoption of purpose-built, enterprise-grade Generative AI (GenAI) services, resulting...

2nd Annual Pharma Impurity Conclave 2024

The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety.

© 2024 India Pharma Outlook. All Rights Reserved.